Nephros (NEPH) Total Current Liabilities (2010 - 2026)

Nephros has reported Total Current Liabilities for 17 years, with the latest figure at $3.3 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 88.71% year-over-year to $3.3 million in Q2 2026; TTM through Jun 2026 was $3.3 million, a 88.71% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 77.14% from the prior year.
• Total Current Liabilities was $3.3 million for Q2 2026 at Nephros, up from $2.5 million in the prior quarter.
• The five-year high for Total Current Liabilities was $3.3 million in Q2 2026, with the low at $1.1 million in Q3 2024.
• Average Total Current Liabilities over 5 years is $1.9 million, with a median of $1.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Total Current Liabilities sank 43.3% in 2023, then soared 133.18% in 2025.
• Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then surged by 49.65% to $2.1 million in 2023, then fell by 26.08% to $1.6 million in 2024, then surged by 77.14% to $2.8 million in 2025, then climbed by 20.85% to $3.3 million in 2026.
• The last three Total Current Liabilities figures came in at $3.3 million (Q2 2026), $2.5 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.